This issue of Vital Signs, released on August 11, 2008, provides an strategic overview of developments and trends in the area of epigenetics. Additionally, a company spotlight is provided for OncoMethylome Sciences, a molecular diagnostics company focused in Oncology. Reimbursement and regulatory news from the FDA is also provided for July 21-24, 2008.

This issue of Vital Signs, released on August 11, 2008, provides an strategic overview of developments and trends in the area of epigenetics. Additionally, a company spotlight is provided for OncoMethylome Sciences, a molecular diagnostics company focused in Oncology. Reimbursement and regulatory news from the FDA is also provided for July 21-24, 2008. Read Less